BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667


SEARCH JOBS


Industry
Biotechnology






 Company News
Adaptive Biotechnologies Hauls In $105 Million 4/7/2014 10:17:52 AM    More...
Adaptive Biotechnologies Announces A Biomarker Discovery Agreement With Johnson & Johnson Innovation (JNJ) 1/13/2014 11:45:40 AM    More...
Adaptive Biotechnologies CEO Selected To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 9:17:16 AM    More...
Adaptive Biotechnologies Publishes "Gold Standard" Method for Sequencing Cells of the Adaptive Immune System 10/28/2013 8:38:18 AM    More...
Adaptive Biotechnologies Receives Critical Intellectual Property for Next Generation Immunosequencing Field 10/17/2013 10:08:45 AM    More...
Adaptive Biotechnologies Study Reveals Homogeneous Immune Repertoire in Solid Tumors 10/8/2013 9:40:12 AM    More...
Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants 9/13/2013 10:00:55 AM    More...
Adaptive Biotechnologies Aims for $20 Million Funding Round 7/16/2013 8:22:26 AM    More...
Adaptive Biotechnologies and Biogen Idec, Inc. (Massachusetts) (BIIB) Sign Immunological Services Agreement 6/27/2013 11:10:02 AM    More...
Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement With Bristol-Myers Squibb Company (BMY) 5/9/2013 10:02:30 AM    More...
12

//-->